forehead & glabellar lines. Other disorders of skin and subcutaneous tissue, not elsewhere classified
Conditions
Interventions
For all individuals botulinum toxin (Dysport) in 2 ml saline normal for subdermal injection according to the Dysport company protocol will be administered..
Treatment - Drugs
For all individuals botulinum toxin (Dysport) in 2 ml saline normal for subdermal injection according to the Dysport company protocol will be administered.
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (to be 18 to 55 years old; not to be pregnant) Exclusion criteria: (to perform other cosmetic procedures during the study; presence of visible scar; prior cosmetic procedures which might interfere with Dysport response; significant facial asymetria; ptosis; dermatochalasis; failure in reduction of glabellar lines even with physical traction; neurologic disorders such as myasthenia gravis; ALS and neuromascular disorders or history of facial weakness; infection of injection site; use of aminoglycosides of any kind)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to the treatment. Timepoint: 2, 8, 12, 16, 20, 24 weeks after the treatment. Method of measurement: Physical examination and taking pictures from the lines. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: 2, 4, 8, 12, 16, 20, 24 weeks after the treatment. Method of measurement: Physical examination and history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMorteza Mohammadi
Tabriz University of Medical Sciences
Outcome results
None listed